Accelerated approval: BIO sets the record straight - Bio.News
The accelerated approval pathway provides incredible benefit to patients with serious unmet medical need, and there’s data to back it up.| Bio.News
The accelerated approval pathway provides incredible benefit to patients with serious unmet medical need, and there’s data to back it up.| Bio.News
Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint| U.S. Food and Drug Administration
